[ET Net News Agency, 3 June 2026] INNOGEN-B (02591) rose 10.1% to HK$11.03.
It hits an intra-day high of HK$11.1, and an intra-day low of HK$9.73, hitting a historical low. The total shares traded was 2.34 million, with a value of HK$24.37m. The active buy/sell ratio is 64:36, with net buying turnover of HK$6.3m. CHINA INV INFO accounts for greatest net responsive buying turnover of HK$867,939, with volume weighted average price of HK$10.554. MERRILL LYNCH FE accounts for greatest net responsive selling turnover of HK$401,791, with volume weighted average price of HK$9.929.
Basic Information| Nominal | 11.030 | % Chg | +10.08% |
| High | 11.100 | Low | 9.730 |
| Shares Tr | 2.34m | Turnover | 24.37m |
| 10-D SMA | 11.559 | %H.V | 144.282 |
| 20-D SMA | 12.642 | VWAP | 10.392 |
| 50-D SMA | 16.633 | RSI14 | 37.379 |
Status: Hitting a historical low, active buy/sell ratio is 64:36, with net buying turnover of HK$6.3m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| INNOGEN-B (02591) | 11.03 | +10.08 |
| GENSCRIPT BIO (01548) | 14.38 | +18.45 |
| INNOVENT BIO (01801) | 76.55 | -2.92 |
| EVEREST MED (01952) | 28.74 | -3.30 |
| XTALPI (02228) | 7.86 | -2.12 |
| WUXI BIO (02269) | 33.36 | -5.07 |
| BEONE MEDICINES (06160) | 163.70 | -3.02 |
| SKB BIO (06990) | 386.60 | -4.21 |
| AKESO (09926) | 101.40 | -4.79 |
| REMEGEN (09995) | 73.50 | -4.17 |
(ed)
Nominal 
